Alexandros Spyridonnidis

50PUBLICATIONS
155CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyHaematological tumoursCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Sep 26, 2026
ELN vs. IPSS-M in MDS/AML: Which Prognostic System Should Guide Clinical Decision-Making?

|Sep 10, 2026
Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.

|Jul 20, 2026
Allogeneic hematopoietic cell transplantation from haploidentical donors with total body irradiation versus chemo-based regimens for adult AML patients in first complete remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

|Jul 17, 2026
Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.

|Jul 08, 2026
Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT.

|Jul 02, 2026
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

Pageof 9

Frequent Collaborators

31 joint publications

Mohamad Mohty

23 joint publications

Arnon Nagler

22 joint publications

Myriam Labopin

20 joint publications

Bipin Savani